Position in ABBV
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$145,641,525
-$115,885,451 QoQ
Shares Held
669,647
-40.7% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026KBC Group NV holds $2,118,683,406 across 10 Drug Manufacturers - General names. ABBV ranks #7 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
576,203 | $529,974,231 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
2,679,656 | $373,463,655 | |
| 3 | JNJ |
Johnson & Johnson
|
1,269,307 | $310,269,402 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
4,009,205 | $243,158,282 | |
| 5 | PFE |
Pfizer Inc
|
8,471,914 | $237,891,345 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,217,611 | $146,466,425 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
669,647 | $145,641,525 | |
| 8 | AMGN |
Amgen Inc
|
252,179 | $88,729,180 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $145,641,525 | 669,647 | Shares | Defined | 2026-05-07 | |
| 2025-09-30 | $261,526,976 | 1,129,511 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $205,612,944 | 1,107,709 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $231,335,221 | 1,104,120 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $203,741,933 | 1,146,550 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $215,657,836 | 1,092,049 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $117,119,858 | 682,835 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $151,280,120 | 830,753 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $166,165,186 | 1,072,241 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $152,004,232 | 1,019,752 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $120,327,092 | 893,098 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $170,600,006 | 1,070,465 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $225,154,243 | 1,393,195 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $192,280,385 | 1,432,683 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $186,787,196 | 1,219,556 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $124,859,715 | 770,216 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $76,703,286 | 566,494 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $39,928,727 | 370,156 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $44,550,808 | 395,515 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $41,559,400 | 384,027 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $50,659,341 | 472,789 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $57,096,942 | 651,866 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $132,291,363 | 1,347,437 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $56,121,400 | 736,598 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||